188 related articles for article (PubMed ID: 31784868)
1. Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients.
Zhao F; Wang J; Chen M; Chen D; Ye S; Li X; Chen X; Ren G; Yan S
Clin Transl Med; 2019 Nov; 8(1):30. PubMed ID: 31784868
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
[TBL] [Abstract][Full Text] [Related]
4. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
5. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
[TBL] [Abstract][Full Text] [Related]
6. Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy.
Guo Y; Mao S; Zhang A; Zhang J; Wang L; Wang R; Zhang W; Zhang Z; Wu Y; Cao X; Yang B; Yao X
Front Oncol; 2019; 9():638. PubMed ID: 31380277
[No Abstract] [Full Text] [Related]
7. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of multiple metastases and worse overall survival of metastatic pancreatic body and tail cancer: a retrospective cohort study.
Zhang H; Tan Q; Xiang C; Liu X; Zheng Z
Gland Surg; 2024 Apr; 13(4):480-489. PubMed ID: 38720678
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of developing visceral metastases at diagnosis in prostate cancer patients.
Xu N; Wu YP; Ke ZB; Liang YC; Tao X; Chen SH; Li XD; Cai H; Lin YZ; Lin TT; Xue XY
Transl Cancer Res; 2019 Jun; 8(3):928-938. PubMed ID: 35116832
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
[TBL] [Abstract][Full Text] [Related]
11. Sites of metastasis and overall survival in esophageal cancer: a population-based study.
Wu SG; Zhang WW; He ZY; Sun JY; Chen YX; Guo L
Cancer Manag Res; 2017; 9():781-788. PubMed ID: 29255373
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients.
Cui PF; Cong XF; Gao F; Yin JX; Niu ZR; Zhao SC; Liu ZL
World J Clin Cases; 2020 Jan; 8(1):54-67. PubMed ID: 31970170
[TBL] [Abstract][Full Text] [Related]
13. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
15. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
16. The role of cytoreductive radical prostatectomy and lymph node dissection in bone-metastatic prostate cancer: A population-based study.
Zhai T; Ma J; Liu Y; Li H; Peng Y; Guo W; Jia J; Wu X; Jiang H; Tian J; Wang D
Cancer Med; 2023 Aug; 12(16):16697-16706. PubMed ID: 37366247
[TBL] [Abstract][Full Text] [Related]
17. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma.
Tufano A; Cordua N; Nardone V; Ranavolo R; Flammia RS; D'Antonio F; Borea F; Anceschi U; Leonardo C; Morrione A; Giordano A
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142956
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognosis of synchronous distant metastatic tonsil squamous cell carcinomas.
Li Y; Hu C
Int J Med Sci; 2021; 18(2):528-533. PubMed ID: 33390822
[TBL] [Abstract][Full Text] [Related]
20. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
